Newsroom

Pseudomonas aeruginosa
Story
More and more resistant pathogens are spreading that cannot be harmed by traditional antibiotics. They are a great danger to the public health systems throughout the world. Without a major change in medical research and development, diseases that can be treated today may become incurable in just a few years. A small wound on a finger may suddenly turn life-threatening, since more and more bacteria become resistant to common antibiotics. The development of resistance is a natural effect of evolution. Resistance arises during the use of antibiotics as some bacteria that are immune to the medication due to genetic variance survive the treatment and then continue to proliferate. Meanwhile, the World Health Organization (WHO) considers antibiotic resistances to be one of the “major threats to global health and food safety”. They cause longer stays in hospital and therefore increasing costs of therapy and higher mortality. The spreading of resistances can be explained by a number of reasons, for example overly eager administration of antibiotics in the treatment of the symptoms of common colds, the use of antibiotics for insufficient periods of time or the improper use in animal husbandry. But one fact is clear: Solutions must be found rapidly by innovative research.
01.11.2018
Scientists stand in front of a screen on which the online monitoring system SORMAS is displayed.
Story
In autumn 2017, Nigeria suspected an outbreak of human monkey pox. Immediately, epidemiologists adapted their online disease surveillance system and travelled to Nigeria to support the locals. The 2014 Ebola outbreak in West Africa revealed an urgent need of efficient disease surveillance systems, because it became evident that the outcome of an epidemic also depends on how fast disease control measures are implemented. HZI scientists from the Department of Epidemiology, led by Gérard Krause, teamed up with Nigerian scientists and developed a mobile-based application, which allows real-time data collection and application of disease control measures called Surveillance, Outbreak Response Management and Analysis System (SORMAS).
01.05.2018
Thomas Ebensen administers a new vaccine in a mouse via the mucous membranes – in humans, this might be done with a nasal spray in the future
Story
Vaccination affords the best protection from many infectious diseases. Vaccines are usually administered with a syringe, but researchers are working on alternatives – like a nasal spray or a vaccination cream. These would not only avoid the unpleasant injection, but even increase the effectiveness. Vaccines usually contain killed or attenuated pathogens and are injected into the patient. This ensures that the entire vaccine truly ends up inside the body. Recognising the pathogens in the vaccine as dangerous foreign material, the immune system prepares itself for defence. The administration by injection with a syringe has its drawbacks as well: It is not the natural pathway of infection and the elicited immune response therefore does not always afford optimal protection from the pathogen. Vaccination also requires trained personnel that simply is not available everywhere and at all times, especially in less developed countries.
01.12.2017
gut mucosa
Story
Over the past few years, public awareness of the microbial communities in our gut has grown significantly – partially thanks to Giulia Enders' book "Gut: The Inside Story Of Our Body's Most Under-Rated Organ". Scientific studies on antibiotics and the microbiota have also attracted attention: The use of these products is hypothesised to disrupt the sensitive inhabitants of our intestine and may cause serious damage. So how can we protect our gut flora against this?
04.09.2017

HZI in the media

Scientists from the University of Vienna and the Helmholtz Institute for Pharmaceutical Research Saarland cultivated the bacteria in a lab

16.05.2025
|
IFL Science

JMU) Würzburg und des Würzburger Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI) haben 2020 eine innovative ...

16.05.2025
|
Biermann Medizin

Medizinische Hochschule Hannover (MHH) und Helmholtz-Zentrum für Infektionsforschung (HZI), wurden kultivierte Methicillin-resistente ...

15.05.2025
|
wallstreet:online

... Forschungsgruppe unter Leitung des Helmholtz-Zentrums für Infektionsforschung ( HZI ) in Braunschweig entdeckt. Die ...

15.05.2025
|
Deutsches Ärzteblatt

... der Fachzeitschrift Angewandte Chemie. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

15.05.2025
|
Verband Deutscher Biologen e.V.

including the University of Vienna and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), have turned to the study of

14.05.2025
|
Phys.org

Register now for the HZI-Newsletter

and stay up to date!

CAPTCHA image for SPAM prevention If you can't read the word, click here.